Literature DB >> 8660704

The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection.

D A Wink1, J A Cook, R Pacelli, W DeGraff, J Gamson, J Liebmann, M C Krishna, J B Mitchell.   

Abstract

The role that nitric oxide (NO) plays in various degenerative and disease states has remained a mystery since its discovery as a biological messenger, prompting the question, "NO, friend or foe?" Some reports have suggested that NO is cytotoxic, and yet others have shown that it possesses protective properties against reactive oxygen species (ROS). Many studies have used various NO donor complexes arriving at seemingly different conclusions. This report will address the effects of various NO donor compounds on ROS-mediated toxicity. Consistent with our previous study, the NO donor compound, DEA/NO ((C2H5)2N[N(O)NO]-Na+), afforded protection against hydrogen peroxide-mediated cytotoxicity in V79 Chinese hamster lung fibroblasts at concentrations as low as 10 microM DEA/NO. Furthermore, a survey of other NO donor complexes revealed that some either protected or potentiated hydrogen peroxide-mediated cytotoxicity. 3-Morpholinosynodiomine.HCl (SIN-1) and sodium nitroprusside (SNP) enhanced hydrogen peroxide-mediated cytotoxicity, while S-nitrosoglutathione (GSNO), and S-nitroso-N-acetylpenicillamine (SNAP) afforded protection. Electrochemical detection of NO in cell culture medium revealed that neither 1000 microM SIN-1 nor SNP yielded appreciable NO concentrations (<0.3 microM). In contrast, DEA/NO, SNAP, and GSNO yielded fluxes of NO >1.0 microM. Thus, a direct correlation between inhibition of hydrogen peroxide cytotoxicity and NO production was observed: agents that release NO during hydrogen peroxide treatment afford significant protection, whereas agents that do not release NO do not protect. Similar results were observed for NO donors studied when hypoxanthinesolidusxanthine oxidase was used as the source for ROS, although the S-nitrosothiol agents were much less protective. These results demonstrate that NO possesses properties which protect against ROS toxicity and demonstrate how the use of different NO donor compounds can lead to different conclusions about the role that NO can play in the cytotoxicity of ROS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660704     DOI: 10.1006/abbi.1996.0304

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  28 in total

1.  Nitric oxide and cGMP activate Ca2+-release processes in rat parotid acinar cells.

Authors:  D K Looms; K Tritsaris; B Nauntofte; S Dissing
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

Review 2.  Nitric oxide and the gut.

Authors:  D Jourd'heuil; M B Grisham; D N Granger
Journal:  Curr Gastroenterol Rep       Date:  1999-10

3.  Effect of L-arginine and L-lysine on lysosomal hydrolases and membrane bound phosphatases in experimentally induced myocardial infarction in rats.

Authors:  Kesavarao Kumar Ebenezar; Venkatachalem Sathish; Thiruvengadam Devaki
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

4.  Age-related changes in nitric oxide activity, cyclic GMP, and TBARS levels in platelets and erythrocytes reflect the oxidative status in central nervous system.

Authors:  Elisa Mitiko Kawamoto; Andrea Rodrigues Vasconcelos; Sabrina Degaspari; Ana Elisa Böhmer; Cristoforo Scavone; Tania Marcourakis
Journal:  Age (Dordr)       Date:  2012-01-26

5.  Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals.

Authors:  C C Chiueh; T Andoh; A R Lai; E Lai; G Krishna
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

6.  Sesamol induces nitric oxide release from human umbilical vein endothelial cells.

Authors:  Pey-Rong Chen; Chingmin E Tsai; Hang Chang; Tsuei-Ling Liu; Chun-Chung Lee
Journal:  Lipids       Date:  2005-09       Impact factor: 1.880

7.  Nitric oxide reduces oxidative stress in cancer cells by forming dinitrosyliron complexes.

Authors:  Sumit Sahni; Jason R Hickok; Douglas D Thomas
Journal:  Nitric Oxide       Date:  2018-03-06       Impact factor: 4.427

Review 8.  Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.

Authors:  R M Pluta
Journal:  Acta Neurochir Suppl       Date:  2008

9.  Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL.

Authors:  Mamta Chawla-Sarkar; Joseph A Bauer; Joseph A Lupica; Bei H Morrison; Zhuo Tang; Rhonda K Oates; Alex Almasan; Joseph A DiDonato; Ernest C Borden; Daniel J Lindner
Journal:  J Biol Chem       Date:  2003-07-24       Impact factor: 5.157

10.  Evidence suggesting a nitric oxide-scavenging activity for traditional crude drugs, and action mechanisms of Sanguisorbae Radix against oxidative stress and aging.

Authors:  T Yokozawa; C P Chen
Journal:  J Am Aging Assoc       Date:  2001-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.